Europe Genetic Testing Market- Industry Trends and Forecast to 2033

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	289 Pages	Data Bridge Market Research	December, 2023	DAABD18458933

Best Price Guarantee
Price	from $3,500
Length	289 Pages
Publisher	Data Bridge Market Research
Published Date	December, 2023
SKU	DAABD18458933

Europe Genetic Testing Market- Industry Trends and Forecast to 2033

Europe genetic testing market is expected to reach USD 17,537,937.49 thousand by 2031 from USD 5,533,644.49 thousand in 2023 with growing at a CAGR of 15.8% during the forecast period of 2024 to 2031.
Market Segmentation
Europe Genetic Testing Market, By Type (Carrier Testing, Diagnostic Testing, New Born Screening, Predictive and Presymptomatic Testing, and Other Types), Technology (DNA sequencing, Polymerase Chain Reaction, Microarrays, Whole Genome Sequencing, Fluorescence In Situ Hybridization (FISH), and Others), Diseases (Rare Genetic Disorder, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s Disease, Fragile X Syndrome, and Other Diseases), End User (Hospitals, Clinics, Diagnostic Centers, Private Clinics, Laboratory Service Providers, and Private Laboratories), By Country (Germany, France, U.K. Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and Rest of Europe) - Industry Trends and Forecast to 2031

Overview of Global Genetic Testing Market Dynamics

Driver
• Growing prevalence of genetic disorders

Restrain

• High cost of genetic testing

Opportunity

• Strategic initiatives by the key market player

Market Players

Some of the key market players for Europe genetic testing market are:

• Thermo Fisher Scientific Inc.
• Invitae Corporation
• Bio-Rad Laboratories, Inc.
• PerkinElmer Inc.
• Illumina, Inc.
• QIAGEN
• F. Hoffmann-La Roche Ltd.
• Fulgent Genetics
• Myriad Genetics, Inc.
• Abbott
• Eurofins Scientific
• Sorenson Genomics
• BIO-HELIX
• Biocartis
• Cepheid (A subsidiary of Danaher)
• PacBio
• ELITechGroup
• Genes2Me
• Eugene Labs
• Otogenetics
• Mapmygenome
• MedGenome
• BioReference
• Natera, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Europe Genetic Testing Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Type Lifeline Curve; 2.7 Primary Interviews With Key Opinion Leaders; 2.8 Dbmr Market Position Grid; 2.9 Market Application Coverage Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestal Analysis; 4.2 Porters 5 Forces; 4.3 Epidemiology
5 Europe Genetic Testing Market: Regulations
6 Market Overview: 6.1 Drivers; 6.1.1 Growing Prevalence Of Genetic Disorders; 6.1.2 Increase In The Adoption Of Next Generation Sequencing; 6.1.3 Wide Product Portfolio Offered By A Major Player; 6.1.4 Increase The Trend Toward Personalized Medication; 6.2 Restraints; 6.2.1 High Cost Of Genetic Testing; 6.2.2 Cyber Security Concerns In Genomics; 6.3 Opportunities; 6.3.1 Strategic Initiatives By The Key Market Player; 6.3.2 Technological Advancement In The Field Of Genetic Testing; 6.3.3 Increasing Research And Development For Genetic Testing; 6.4 Challenges; 6.4.1 Lack Of Skilled Professionals To Perform Genetic Testing; 6.4.2 Stringent Regulation Policy For Genetic Testing
7 Europe Genetic Testing Market, By Type: 7.1 Overview; 7.2 Diagnostic Testing; 7.3 Prenatal Testing; 7.3.1 Non-invasive Screening; 7.3.1.1 Whole Genome Sequencing; 7.3.1.2 Counting Of Cfdna Fragments; 7.3.1.3 Others; 7.3.2 By Condition; 7.3.2.1 Trisomy 21; 7.3.2.2 Klinefelter Syndrome; 7.3.2.3 Jacobs Syndrome; 7.3.2.4 Cystic Fibrosis; 7.3.2.5 Turner Syndrome; 7.3.2.6 Trisomy 18; 7.3.2.7 Hemophilia; 7.3.2.8 Trisomy 13; 7.3.2.9 Microdeletion Syndrome; 7.3.2.10 Fetal Gender; 7.3.2.11 Others; 7.3.3 By Screening Type; 7.3.3.1 Carrier Sequencing; 7.3.3.2 Sequential Sequencing; 7.3.4 Maternal Serum Quad Screening; 7.4 New-born Screening; 7.4.1 Sickle Cell Disease; 7.4.2 Congenital Hypothyroidism; 7.4.3 Phenylketonurina (Pku); 7.4.4 Galactosemia; 7.4.5 Maple Syrup Urine Disease; 7.4.6 Others 81; 7.5 Predictive And Presymptomatic Testing; 7.6 Carrier Testing; 7.6.1 Molecular Screening Test; 7.6.2 Biochemical Screening Test; 7.6.2.1 Expanded Carrier Screening; 7.6.2.2 Predesigned Panel Testing; 7.6.2.3 Custom-made Panel Testing; 7.6.2.4 Targeted Disease Carrier Screening; 7.6.2.4.1 Hematological Conditions; 7.6.2.4.2 Pulmonary Conditions; 7.6.2.4.3 Neurological Conditions; 7.6.2.4.4 Other Conditions; 7.7 Other Types
8 Europe Genetic Testing Market, By Technology: 8.1 Overview; 8.2 Polymerase Chain Reaction; 8.2.1 Real-time Pcr (Qpcr); 8.2.2 Digital Pcr (Dpcr); 8.2.3 Reverse Transcription Pcr (Rt-pcr); 8.2.4 Hot-start Pcr; 8.2.5 Multiplex Pcr; 8.2.6 Other Pcr; 8.3 Dna Sequencing (Ngs-based Testing); 8.3.1 Next Generation Sequencing (Ngs); 8.3.2 Sanger Sequencing (Single Gene); 8.3.3 Other; 8.4 Whole Genome Sequencing; 8.5 Microarrays; 8.5.1 Dna Microarrays; 8.5.2 Protein Microarrays; 8.5.3 Other Microarrays; 8.6 Fluorescence In Situ Hybridization (Fish); 8.7 Others
9 Europe Genetic Testing Market, By Diseases: 9.1 Overview; 9.2 Cancer; 9.2.1 Breast; 9.2.2 Colon; 9.2.3 Lung; 9.2.4 Prostate; 9.2.5 Others; 9.3 Sickle Cell Anemia; 9.4 Thalassemia; 9.5 Rare Genetic Disorder; 9.5.1 Trisomy 21; 9.5.2 Monosomy X; 9.5.3 Trisomy 13; 9.5.4 Microdeletion Syndrome; 9.5.5 Trisomy 18; 9.5.6 Others; 9.6 Fragile X Syndrome; 9.7 Duchenne Muscular Dystrophy; 9.8 Huntington's Disease; 9.9 Cystic Fibrosis; 9.10 Others
10 Europe Genetic Testing Market, By End User: 10.1 Overview; 10.2 Hospitals; 10.3 Clinics; 10.4 Diagnostic Centers; 10.5 Private Clinics; 10.6 Laboratory Service Providers; 10.7 Private Laboratories 114
11 Europe Genetic Testing Market, By Region: 11.1 Europe; 11.1.1 Germany; 11.1.2 France; 11.1.3 U.K.; 11.1.4 Russia; 11.1.5 Italy; 11.1.6 Spain; 11.1.7 Turkey; 11.1.8 Netherlands; 11.1.9 Switzerland; 11.1.10 Belgium; 11.1.11 Rest Of Europe
12 Europe Genetic Testing Market, Company Landscape: 12.1 Company Share Analysis: Europe
13 Swot Analysis
14 Company Profiles: 14.1 Illumina, Inc.; 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Development; 14.2 Cepheid; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Development; 14.3 Fulgent Genetics; 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Development 245; 14.4 Perkinelmer Inc.; 14.4.1 Company Snapshot; 14.4.2 Revenue Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Development; 14.5 Thermo Fisher Scientific Inc.; 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Development; 14.5.5.1 Collaboration; 14.6 Bioreference; 14.6.1 Company Snapshot; 14.6.2 Revenue Analysis; 14.6.3 Product Portfolio; 14.6.4 Recent Development; 14.7 Elitechgroup; 14.7.1 Company Snapshot; 14.7.2 Product Portfolio; 14.7.3 Recent Developments; 14.8 Eurofins Scientific; 14.8.1 Company Snapshot; 14.8.2 Revenue Analysis; 14.8.3 Product Portfolio; 14.8.4 Recent Development; 14.9 Invitae Corporation; 14.9.1 Company Snapshot; 14.9.2 Revenue Analysis; 14.9.3 Product Portfolio; 14.9.4 Recent Developments; 14.10 Myriad Genetics; 14.10.1 Company Snapshot; 14.10.2 Revenue Analysis; 14.10.3 Product Portfolio; 14.10.4 Recent Development 260; 14.11 Abbott; 14.11.1 Company Snapshot; 14.11.2 Revenue Analysis; 14.11.3 Product Portfolio; 14.11.4 Recent Development; 14.12 Biocartis; 14.12.1 Company Snapshot; 14.12.2 Revenue Analysis; 14.12.3 Product Portfolio; 14.12.4 Recent Developments; 14.12.4.1 Partnership; 14.13 Bio-helix; 14.13.1 Company Snapshot; 14.13.2 Product Portfolio; 14.13.3 Recent Development; 14.14 Bio-rad Laboratories, Inc.; 14.14.1 Company Snapshot; 14.14.2 Revenue Analysis; 14.14.3 Product Portfolio; 14.14.4 Recent Developments; 14.15 Eugene Labs; 14.15.1 Company Snapshot; 14.15.2 Product Portfolio; 14.15.3 Recent Development; 14.16 F. Hoffmann-la Roche Ltd; 14.16.1 Company Snapshot; 14.16.2 Revenue Analysis (Parent Company); 14.16.3 Product Portfolio; 14.16.4 Recent Development; 14.17 Genes2me; 14.17.1 Company Snapshot; 14.17.2 Product Portfolio; 14.17.3 Recent Development; 14.18 Mapmygenome; 14.18.1 Company Snapshot; 14.18.2 Product Portfolio; 14.18.3 Recent Development 273; 14.19 Medgenome; 14.19.1 Company Snapshot; 14.19.2 Product Portfolio; 14.19.3 Recent Development; 14.20 Natera, Inc.; 14.20.1 Company Snapshot; 14.20.2 Revenue Analysis; 14.20.3 Product Portfolio; 14.20.4 Recent Development; 14.21 Otogenetics; 14.21.1 Company Snapshot; 14.21.2 Product Portfolio; 14.21.3 Recent Development; 14.22 Pacbio; 14.22.1 Company Snapshot; 14.22.2 Revenue Analysis; 14.22.3 Product Portfolio; 14.22.4 Recent Development; 14.23 Qiagen; 14.23.1 Company Snapshot; 14.23.2 Revenue Analysis; 14.23.3 Product Portfolio; 14.23.4 Recent Development; 14.24 Sorenson Genomics; 14.24.1 Company Snapshot; 14.24.2 Product Portfolio; 14.24.3 Recent Development
15 Questionnaire
16 Related Reports
List Of Tables: Table 1 Europe Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 2 Europe Genetic Testing Market, By Type, 2022-2031 (Units); Table 3 Europe Diagnostic Testing In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 4 Europe Prenatal Testing In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 5 Europe Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 6 Europe Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Uunits); Table 7 Europe Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Usd Thousand); Table 8 Europe Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Units); Table 9 Europe Non-invasive Screening In Genetic Testing Market, By Condition, 2022-2031 (Usd Thousand); Table 10 Europe Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Usd Thousand); Table 11 Europe Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Units); Table 12 Europe New Born Screening In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 13 Europe New-born Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 14 Europe Predictive And Presymptomatic Testing In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 15 Europe Carrier Testing In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 16 Europe Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Usd Thousand); Table 17 Europe Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Units); Table 18 Europe Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 19 Europe Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 20 Europe Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 21 Europe Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Units); Table 22 Europe Carrier Testing In Genetic Testing Market, By Medical Condition, 2022-2031 (Usd Thousand); Table 23 Europe Other Types In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 24 Europe Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 25 Europe Polymerase Chain Reaction In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 26 Europe Polymerase Chain Reaction In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 27 Europe Dna Sequencing (Ngs-based Testing) In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 28 Europe Dna Sequencing (Ngs-based Testing) In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 29 Europe Whole Genome Sequencing In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 30 Europe Microarrays In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 31 Europe Microarrays In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 32 Europe Fluorescence In Situ Hybridization (Fish) In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 33 Europe Others In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 34 Europe Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 1 Europe Cancer In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 2 Europe Cancer In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 3 Europe Sickle Cell Anemia In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 4 Europe Thalassemia In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 5 Europe Rare Genetic Disorder In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 6 Europe Rare Genetic Disorder In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 7 Europe Fragile X Syndrome In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 8 Europe Duchenne Muscular Dystrophy In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 9 Europe Huntington's Disease In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 10 Europe Cystic Fibrosis In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 11 Europe Others In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 12 Europe Genetic Testing Market, By End User, 2022-2031 (Usd Thousand); Table 13 Europe Hospitals In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 14 Europe Clinics In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 15 Europe Diagnostic Centers In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 16 Europe Private Clinics In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 17 Europe Laboratory Service Providers In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 18 Europe Private Laboratories In Genetic Testing Market, By Region, 2022-2031 (Usd Thousand); Table 19 Europe Genetic Testing Market, By Country, 2022-2031 (Usd Thousand); Table 20 Europe Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 21 Europe Genetic Testing Market, By Type, 2022-2031 (Units); Table 22 Europe Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 23 Europe Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 24 Europe Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Usd Thousand); Table 25 Europe Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Units); Table 26 Europe Non-invasive Screening In Genetic Testing Market, By Condition, 2022-2031 (Usd Thousand); Table 27 Europe Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Usd Thousand); Table 28 Europe Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Units); Table 29 Europe New-born Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 30 Europe Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Usd Thousand); Table 31 Europe Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Units); Table 32 Europe Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 33 Europe Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 34 Europe Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 35 Europe Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Units); Table 36 Europe Carrier Testing In Genetic Testing Market, By Medical Condition, 2022-2031 (Usd Thousand); Table 37 Europe Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 38 Europe Polymerase Chain Reaction In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 39 Europe Dna Sequencing In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 40 Europe Microarrays In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 41 Europe Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 42 Europe Rare Genetic Disorder In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 43 Europe Cancer In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 44 Europe Genetic Testing Market, By End User, 2022-2031 (Usd Thousand); Table 45 Germany Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 46 Germany Genetic Testing Market, By Type, 2022-2031 (Units); Table 47 Germany Genetic Testing Market, By Type, 2022-2031 (Asp); Table 48 Germany Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 49 Germany Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 50 Germany Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 51 Germany Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Usd Thousand); Table 52 Germany Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Units); Table 53 Germany Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Asp); Table 54 Germany Non-invasive Screening In Genetic Testing Market, By Condition, 2022-2031 (Usd Thousand); Table 55 Germany Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Usd Thousand); Table 56 Germany Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Units); Table 57 Canada Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Asp); Table 58 Germany New-born Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 59 Germany Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Usd Thousand); Table 60 Germany Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Units); Table 61 Germany Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Asp); Table 62 Germany Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 63 Germany Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 64 Germany Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 65 Germany Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 66 Germany Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Units); Table 67 Germany Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 68 Germany Carrier Testing In Genetic Testing Market, By Medical Condition, 2022-2031 (Usd Thousand); Table 69 Germany Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 70 Germany Polymerase Chain Reaction In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 71 Germany Dna Sequencing In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 72 Germany Microarrays In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 73 Germany Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 74 Germany Rare Genetic Disorder In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 75 Germany Cancer In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 76 Germany Genetic Testing Market, By End User, 2022-2031 (Usd Thousand); Table 77 France Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 78 France Genetic Testing Market, By Type, 2022-2031 (Units); Table 79 France Genetic Testing Market, By Type, 2022-2031 (Asp); Table 80 France Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 81 France Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 82 France Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 83 France Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Usd Thousand); Table 84 France Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Units); Table 85 France Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Asp); Table 86 France Non-invasive Screening In Genetic Testing Market, By Condition, 2022-2031 (Usd Thousand); Table 87 France Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Usd Thousand); Table 88 France Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Units); Table 89 France Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Asp); Table 90 France New-born Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 91 France Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Usd Thousand); Table 92 France Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Units); Table 93 France Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Asp); Table 94 France Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 95 France Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 96 France Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 97 France Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 98 France Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Units); Table 99 France Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 100 France Carrier Testing In Genetic Testing Market, By Medical Condition, 2022-2031 (Usd Thousand); Table 101 France Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 102 France Polymerase Chain Reaction In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 103 France Dna Sequencing In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 104 France Microarrays In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 105 France Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 106 France Rare Genetic Disorder In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 107 France Cancer In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 108 France Genetic Testing Market, By End User, 2022-2031 (Usd Thousand); Table 109 U.K. Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 110 U.K. Genetic Testing Market, By Type, 2022-2031 (Units); Table 111 U.K. Genetic Testing Market, By Type, 2022-2031 (Asp); Table 112 U.K. Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 113 U.K. Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 114 U.K. Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 115 U.K. Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Usd Thousand); Table 116 U.K. Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Units); Table 117 U.K. Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Asp); Table 118 U.K. Non-invasive Screening In Genetic Testing Market, By Condition, 2022-2031 (Usd Thousand); Table 119 U.K. Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Usd Thousand); Table 120 U.K. Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Units); Table 121 U.K. Non-invasive Screening In Genetic Testing Market, By Screening Type, 2022-2031 (Asp); Table 122 U.K. New-born Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 123 U.K. Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Usd Thousand); Table 124 U.K. Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Units); Table 125 U.K. Carrier Testing In Genetic Testing Market, By Test Type, 2022-2031 (Asp); Table 126 U.K. Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 127 U.K. Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 128 U.K. Carrier Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 129 U.K. Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 130 U.K. Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Units); Table 131 U.K. Expanded Carrier Screening In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 132 U.K. Carrier Testing In Genetic Testing Market, By Medical Condition, 2022-2031 (Usd Thousand); Table 133 U.K. Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 134 U.K. Polymerase Chain Reaction In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 135 U.K. Dna Sequencing In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 136 U.K. Microarrays In Genetic Testing Market, By Technology, 2022-2031 (Usd Thousand); Table 137 U.K. Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 138 U.K. Rare Genetic Disorder In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 139 U.K. Cancer In Genetic Testing Market, By Diseases, 2022-2031 (Usd Thousand); Table 140 U.K. Genetic Testing Market, By End User, 2022-2031 (Usd Thousand); Table 141 Russia Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 142 Russia Genetic Testing Market, By Type, 2022-2031 (Units); Table 143 Russia Genetic Testing Market, By Type, 2022-2031 (Asp); Table 144 Russia Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Usd Thousand); Table 145 Russia Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Units); Table 146 Russia Prenatal Testing In Genetic Testing Market, By Type, 2022-2031 (Asp); Table 147 Russia Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Usd Thousand); Table 148 Russia Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Units); Table 149 Russia Non-invasive Screening In Genetic Testing Market, By Screening Method, 2022-2031 (Asp)
List Of Figures: Figure 1 Europe Genetic Testing Market: Segmentation; Figure 2 Europe Genetic Testing Market: Data Triangulation; Figure 3 Europe Genetic Testing Market: Droc Analysis; Figure 4 Europe Genetic Testing Market: Europe Vs Regional Market Analysis; Figure 5 Europe Genetic Testing Market: Company Research Analysis; Figure 6 Multivariate Modelling; Figure 7 Europe Genetic Testing Market: Dbmr Market Position Grid; Figure 8 Europe Genetic Testing Market: Application Coverage Grid; Figure 9 Europe Genetic Testing Market: Vendor Share Analysis; Figure 10 Europe Genetic Testing Market: Segmentation; Figure 11 Increasing Prevalence Of Genetic Disorders Are Expected To Drive The Europe Genetic Testing Market In The Forecast Period Of 2024 To 2031; Figure 12 Diagnostic Testing Segment Is Expected To Account For The Largest Share Of The Europe Genetic Testing Market In 2024 & 2031; Figure 13 North America Is Expected To Dominate The Europe Genetic Testing Market And Asia-pacific Expected To Grow With The Highest Cagr In The Forecast Period Of 2024 To 2031; Figure 14 Asia-pacific Is The Fastest Growing Market For Genetic Testing Manufacturers In The Forecast Period Of 2024 To 2031; Figure 15 Drivers, Restraints, Opportunities, And Challenges Of Europe Genetic Testing Market; Figure 16 Europe Genetic Testing Market: By Type, 2023; Figure 17 Europe Genetic Testing Market: By Type, 2024-2031 (Usd Thousand); Figure 18 Europe Genetic Testing Market: By Type, Cagr (2024-2031); Figure 19 Europe Genetic Testing Market: By Type, Lifeline Curve; Figure 20 Europe Genetic Testing Market: By Technology, 2023; Figure 21 Europe Genetic Testing Market: By Technology, 2024-2031 (Usd Thousand); Figure 22 Europe Genetic Testing Market: By Technology, Cagr (2024-2031); Figure 23 Europe Genetic Testing Market: By Technology, Lifeline Curve; Figure 24 Europe Genetic Testing Market: By Diseases, 2023; Figure 25 Europe Genetic Testing Market: By Diseases, 2023-2031 (Usd Thousand); Figure 26 Europe Genetic Testing Market: By Diseases, Cagr (2023-2031); Figure 27 Europe Genetic Testing Market: By Diseases, Lifeline Curve; Figure 28 Europe Genetic Testing Market: By End User, 2023; Figure 29 Europe Genetic Testing Market: By End User, 2024-2031 (Usd Thousand); Figure 30 Europe Genetic Testing Market: By End User, Cagr (2024-2031); Figure 31 Europe Genetic Testing Market: By End User, Lifeline Curve; Figure 32 Europe Genetic Testing Market: Snapshot (2023); Figure 33 Europe Genetic Testing Market: Company Share 2023 (%)